Canadian Government Launches Cannabis and Brain Health Consortium

Canada is investing $24 million to establish the Canadian Cannabis and Brain Health Consortium, featuring 10 multidisciplinary research teams investigating cannabis's therapeutic potential and effects on brain health. The consortium will examine cannabis use during prenatal exposure, sleep disorders, and its effects on individuals with psychosis, post-traumatic stress disorder, and epilepsy. This comprehensive research initiative aims to generate evidence-based data on cannabis's safety and efficacy for various neurological and psychiatric conditions. The consortium represents a significant effort to understand how cannabis compounds may benefit brain health while identifying potential risks, supporting informed clinical decision-making across Canada.
Originally published on
Ganjapreneur
By TG Branfalt
Read full article(opens in new tab)Fetched: August 18, 2026 at 10:02 AM

